Delivery Order SPE2DB20D3103-SPE2DB25FQ3K6
- Not listed
- The Defense Logistics Agency (DLA) awarded a $30,760.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.44ML, a pharmaceutical product used in fertility treatment. This non-set-aside award, issued on July 18, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $38,412.50 for GONAL-F RFF Redi-Ject 900 Unit 1.44ML, a pharmaceutical product, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $10,975 delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a fertility medication used in assisted reproductive treatments. This firm fixed price delivery order, issued on April 10, 2025, with an ultimate completion date of April 11, 2025, represents a non-set-aside competitive award. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $31,639.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product used in fertility treatment. The award, issued on June 20, 2025, with an ultimate completion date of June 23, 2025, represents a non-competitive delivery order. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of GONAL-F RFF Redi-Ject 900 Unit 1.44ML, a pharmaceutical product, with a ceiling value of $10,975.00. Issued on September 9, 2025, with an ultimate completion date of September 10, 2025, this firm fixed-price delivery order represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of GONAL-F RFF Redi-Ject 900 Unit 1.44ML pharmaceutical product with a ceiling value of $33,834.30. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract was competitively awarded without set-aside provisions, reflecting...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $16,462.50 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 8, 2025, for the supply of GONAL-F RFF REDI-JECT 900 Unit 1.44ML, a pharmaceutical product. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award selection. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Department's Medical Supply Chain awarded a $28,361.19 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of GONAL-F RFF Redi-Ject 450 Unit 0.72ML pharmaceutical product. The contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open procurement. Performance will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania, with completion scheduled for August...
- On July 22, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $40,816.93 to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.44ML pharmaceutical products. This firm fixed-price, non-set-aside delivery order is scheduled for completion by July 23, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $44,642.84 contract is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty pharmaceutical product. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3K6Delivery Order
The Defense Logistics Agency (DLA) awarded a $78,014.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Gonal-F RFF Redi-Ject 900 Unit 1.44mL, a pharmaceutical product used in fertility treatment. The contract, awarded on September 16, 2025, with a completion date of September 17, 2025, was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems. The company's substantial IDC with DLA enables it to supply a diverse range of pharmaceutical products, medical devices, and specialty medications across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. The delivery order will be performed at the company's Conshohocken facility, demonstrating AmerisourceBergen's established capability to fulfill federal medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $78.0k | 9/16/25 |